[Studies on drug metabolism. 6. Effect of long-term administration of DAB (4-dimethyaminoazobenzene) on drug-metabolizing enzyme activities].
D000628:Aminophylline / Q000378:metabolism; D000814:Aniline Compounds / Q000378:metabolism; D000821:Animal Feed; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D008297:Male; D008861:Microsomes / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009020:Morphine / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism*; D051381:Rats; D013997:Time Factors; D004124:p-Dimethylaminoazobenzene / Q000494:pharmacology*
D000814:Aniline Compounds; D000628:Aminophylline; D009020:Morphine; D004124:p-Dimethylaminoazobenzene; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases